Repair Impact Fund

company

About

The aim of REPAIR Impact Fund is to increase humanity’s therapeutic arsenal in the fight against antimicrobial resistance.

Details

Operating Status
Active
Investor Type
Hedge Fund

Novo Holdings established the REPAIR Impact Fund commissioned by the Novo Nordisk Foundation in February 2018 to invest in companies involved in discovering and the early-stage development of therapies targeting resistant microorganisms.

REPAIR is an acronym: Replenishing and Enabling the Pipeline for Anti-Infective Resistance.

The Novo Nordisk Foundation is commissioning the initiative, and Novo Holdings is executing it.

Investments

Number of Investments
Number of Lead Investments
3
1
Repair Impact Fund has made 3 investments. Their most recent investment was on Dec 15, 2022, when Minervax raised €22M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 15, 2022 Minervax
Series C €22M Biotechnology
Dec 15, 2020 Minervax
Series B €47.40M Biotechnology
Jan 21, 2019 Minervax
Grant €4.40M Biotechnology Yes